Jefferies Upgrades BioMed Realty (BMR) to Buy
Tweet
Share
E-mailGet Alerts BMR Hot Sheet
Price: $1.23 +1.65%
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Join SI Premium – FREE
Jefferies upgraded BioMed Realty (NYSE: BMR) from Hold to Buy and raised their price target from $19 to $23.
The firm said, "We recommend adding stocks in defensive sectors, but which have offensive characteristics, strong earnings growth, and attractive valuations."
For more ratings news on BioMed Realty click here and for the rating history of BioMed Realty click here.
Shares of BioMed Realty closed at $19.51 yesterday.
The firm said, "We recommend adding stocks in defensive sectors, but which have offensive characteristics, strong earnings growth, and attractive valuations."
For more ratings news on BioMed Realty click here and for the rating history of BioMed Realty click here.
Shares of BioMed Realty closed at $19.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- Meritage Hospitality posts Q2 loss amid restructuring charges
- DB cautious on cruise stocks as fundamentals “not as clear as bulls believe”
Create E-mail Alert Related Categories
UpgradesRelated Entities
Jefferies & Co, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
